was infused at constant rate into the inferior vena cava of eight ovine fetuses with gestational ages ranging from 110 to 145 days. The infusion lasted 9 to 13 h and produced a steady-state specific activity of free lysine in the fetal plasma. In the steady state, approximately 9% of the infused radioactivity was excreted by the fetus as 14C02, indicating fetal catabolism of lysine. At the end of the infusion, the fetal carcass was analyzed for its total content of labeled and unlabeled lysine. The rate of protein synthesis was calculated from the carcassto-plasma lysine specific activity ratio. The fractional rate constant (KS) for the unidirectional flux of lysine into fetal proteins was inversely related (r = -0.88) to fetal age: KS = 0.584 -0.0036 age (days). In each fetus, K, was 2-4 times greater than the estimated fractional rate of fetal protein accretion (KG).
Metab. 3): E320-E324, 1981.-Uniformly labeled ["C]lysine was infused at constant rate into the inferior vena cava of eight ovine fetuses with gestational ages ranging from 110 to 145 days. The infusion lasted 9 to 13 h and produced a steady-state specific activity of free lysine in the fetal plasma. In the steady state, approximately 9% of the infused radioactivity was excreted by the fetus as 14C02, indicating fetal catabolism of lysine. At the end of the infusion, the fetal carcass was analyzed for its total content of labeled and unlabeled lysine. The rate of protein synthesis was calculated from the carcassto-plasma lysine specific activity ratio. The fractional rate constant (KS) for the unidirectional flux of lysine into fetal proteins was inversely related (r = -0.88) to fetal age: KS = 0.584 -0.0036 age (days). In each fetus, K, was [2] [3] [4] times greater than the estimated fractional rate of fetal protein accretion (KG).
The discrepancy between KS and KC demonstrates that a large fraction of protein synthesis in the ovine fetus is devoted to protein turnover.
fetal lysine metabolism; sheep fetus IN 1939 SCHOENHEIMER ET AL. (11) studied the fate of labeled amino acids injected in the rat and for the first time demonstrated that there is both a rapid synthesis and degradation of body proteins. Subsequent investigators have compared rates of total-body protein turnover in several species and at different ages. These studies have shown a relatively higher rate of protein turnover in small mammals (5) . Within a given species, protein turnover appears to be related to the age of the organism.
For example, Young et al. (16) have measured total-body protein turnover in premature newborns, infants, young adults, and the elderly. Rates ranged from 17.4 t 7.9 go kg-' *day-' for the premature newborn to 1.9 t 0.2 go kg-' 'day-' for the elderly.
The inverse relationship of protein turnover to body size and age raises the question of whether rapid protein turnover is an important component of fetal metabolism. To investigate this question, we have studied the rate of incorporation of L-[U-14C]lysine in the body proteins of eight ovine fetuses ranging from 110 to 145 days gestation. Lysine was selected because it is an essential amino acid abundant in body proteins. Furthermore, after deamination, its carbon skeleton is not reutilized for lysine resynthesis (15) .
MATERIALS AND METHODS
Eight mixed-breed Western ewes with gestational ages ranging from 110 to 145 days were studied. Catheters were placed in the fetal abdominal aorta, the fetal inferior vena cava, the umbilical vein, and the maternal femoral artery by surgical techniques previously described (7, 12) . The catheters were exteriorized through a subcutaneous tunnel to a plastic pouch fixed on the ewe's flank. With one exception (animal 3), all animals were standing and eating within 12-24 h after surgery. Catheters were irrigated daily with normal saline containing 30 U heparin/ ml. Following surgery, the ewes were maintained-on an ad libitum diet of hay, dehydrated alfalfa pellets, barley, oats, corn, and water. Experiments were performed on postsurgical day 4 or 5. By means of a calibrated infusion pump, L-[U-14C]lysine was infused at a constant rate into the fetal inferior vena cava for a period of 9-13 h. The amount of radioacti vity infused was approximately lo5 dpm*min-l *kg fetal body wt? At various times during the infusion blood samples were withdrawn from the fetal aorta. In six of the eight animals, umbilical blood flow was measured during part of the infusion period with the antipyrine steady-state desion technique (8).
Simultaneous samples of umbilical venous and fetal arterial blood were withdrawn in these animals for estimating net umbilical lysine uptake (fetuses 1,2,6, and 7) and 14C02 excretion rate (fetuses 5,6, and 8) by means of the Fick principle. At the conclusion of the infusion, the ewe was killed and the uterus was removed. The fetus, uterus, placenta, and fetal membranes were weighed and homogenized separately. Portions of each homogenate (2-3 mg) were weighed and solubilized in TS-1 tissue solubilizer (Radiation Products, Elk Grove Village, IL) for 24-36 h at 50°C. inactive against Dlysine, o-(2aminoethyl) -DL-serine, L-ornithine, and La+-diamino-n-butyric acid (13) . In addition, the acetyl, e-acetyl, or r-carbobenzoxy derivatives of L-lysine are reported not to be substrates for this enzyme (13) . Because the sheep has a relative abundance of c-N-methyllysine, we have documented that this analogue is also not an inhibitor of the enzyme. The use of an enzymatic procedure was made necessary by the finding that a group of proteins that are rapidly labeled by [14C]lysine remained in the supernatant after deproteinization. Following precipitation of the plasma proteins with 10% suIfosalicylic acid, two radioactive fractions could be identified in the supematant using a Sephadex G-75 column (Fig. 1 ). The first fraction with low optical density at 230 nm but high radioactivity appeared with the void volume of the column. This first peak contained several acid-soluble proteins or protein aggregates because analysis by acrylamide-gel electrophoresis demonstrated three major protein bands. The second peak was eluted with the salt fraction of the column and contained free lysine. The enzymatic assay of ['4C]lysine was carried out in specially constructed diffusion vessels. Optimum conditions for decarboxylation were used as specified by Soda and Moriguchi (13) . Typically, 0.2 ml of whole 2 4 
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plasma was added to 0.5 ml of 0.1 M sodium acetate buffer (pH 5.8) in the reaction vessel. An initial 30.min incubation at 37OC in the uncapped diffusion vessel was shov to release the 14C02 originally present in the sample. Following this, the vessels were capped and Llysine decarboxylase was added through the needle orifice. A further incubation at 37OC for 60 min was shown to be sufficient for complete decarboxylation of free lysine in the plasma. The KOH trap was then removed and placed immediately into PCS scintillation fluid. Standards of L-[U-14C]lysine were used to test complete decarboxylation in each experimental group.
Lysine concentrations in plasma, whole blood, and carcass hydrolysate were measured with a JEOL 6AH amino acid analyzer using an internal standard of norleutine to correct for dilution and recovery errors (7) . The diffusion vessels were also used for measuring 14C02 in umbilical venous and fetal arterial blood. Blood samples of approximately 0.5 ml were withdrawn into heparinized glass syringes and incubated in the capped vessels for 24 h at 50°C in the presence of 0.5 M KOH. Measurements of radioactivity were performed in a liquid-scintillation counter. The method of channels ratio for quench correction was used in the analysis of the KOH solutions. Carcass radioactivity was corrected for quenching by the method of serial dilutions.
RESULTS
At the end of infusions lasting from 560 to 775 min, recoveries of the infused radioactivity in the fetal body ranged from 47.1 to 69.1%. The mean values for the distribution of 14C throughout the fetal and maternal compartments are illustrated in Fig. 2 . An average of 61% remained in the fetus, 3% was located in the fetal amniotic and allantoic fluids and membranes, 10% was located in the placental cotyledons, approximately 9% could be accounted for by fetal excretion of 14C02, and the remaining 17% was assumed to have been transferred to the maternal compartment either as lysine or as a metabolic product other than Cog. Virtually all the radioactivity recovered in the fetal carcass after acid hydrolysis was [14C]lysine and of this, greater than 90% was in the bound form.
In a single animal, at the completion of the infusion, the fetus was delivered rapidly and biopsies were taken from muscle, liver, and kidney and promptly frozen in liquid nitrogen. The total time from termination of infusion to freezing the last biopsy sample was less than 5 min. The frozen tissues were homogenized in cold 6% perchloric acid and triplicate aliquots analyzed for total radioactivity and for free [l*C]lysine using the lysine decarboxylase method. The results for the three tissue sites are presented in Table 1 . Preliminary experiments (Fig. 3) showed that whole plasma radioactivity increased throughout the infusion, whereas the concentration of free radioactive lysine reached a plateau at approximately 2 h. On the basis of this information, the mean free [l%]lysine in plasma samples collected 2 or more hours after the infusion was used to calculate the specific activity of free lysine in the plateau period (Fzax). In all but one fetus, the concentration of free radioactive lysine in the sampling period varied within &lo% of the mean and did not show a systematic trend to change with time. In fetus 7 the variability was &20%. At the end of the experiment, the specific activity of lysine in the protein of the whole-body homogenate (P*) was 2.2 to 8.9% of the steady-state specific activity of free plasma lysine (Fzax) (see Table  1 ). In each fetus, the P*/F zax ratio was used to calculate an approximate fractional rate constant, K's, for the unidirectional flux of lysine into fetal protein synthesis, according to the equation K / S = --t-l ln [l -(P* + F:,,)] (0 where t is the duration of the infusion.
comparison to the duration of the experiment. Regression analysis of KS versus fetal age (Fig. 4) shows that there is a significant negative correlation between KS and age (r = 0.879, P < .Ol). Likewise, the two rates derived from KS, namely the unidirectional flux of plasma lysine into proteins (mmol. day-' @kg-') and the rate of protein synthesis (g l day-') are inversely related to age.
Equation 1 is derived from the assumption that the
In three fetuses, whole blood measurements of '*CO2 flux is proportional to the P* -Fza, difference and that showed that the concentration of 14C02 in the arterial the specific activity of lysine is equal to FLaX starting at blood of the fetus was higher than in the umbilical vein time 0. Because the latter assumption is not exactly and that both concentrations were higher than in the correct (see Fig. 4) , a more precise calculation of the rate maternal blood, thus demonstrating production and exconstant KS was made, using Swick's equation (17) cretion of 14C02 by the fetus.
In four animals, the net fetal uptake of lysine via the umbilical circulation was calculated as the product of the umbilical venous-arterial difference of whole blood lysine times the umbilical blood flow. The uptake (mmolmkg-'0 day-l) ranged from 3.9 and 4.1 in fetuses 1 and 2 to 2.2 and 3.4 in fetuses 6 and 7. The mean umbilical blood flow was 226 t 27 ml.kg-l.min? P*/F:,, -1 -
where KF is the rate constant that defines the time course of F*. Equation 2 was derived by Swick for the steady state in which rate of synthesis equals rate of degradation. However, the equation can be applied to a growing organism without substantial error (17) . Each KS was calculated by an iterative procedure using a KF equal to 35 day-' (see Fig. 3 ) and the KL value as the initial estimate. Note that the calculation of KS does not require precise knowledge of KF (17) because KF >> KS and that KS is greater than KL by only 6%. Table 2 presents the KS rate constants as well as the results of rates derived from KB, namely the unidirectional flux of plasma lysine into proteins and the fetal rate of protein synthesis. The latter is a minimal rate because some of the nontracer lysine released by protein degradation is recycled intracellularly, reducing intracellular specific activity. Furthermore, the steady-state method underestimates the synthesis rate of a protein mixture in which some proteins have a short half-life in 
DISCUSSION
Accurate knowledge of protein accretion in the fetus and of the concentration of amino acids in fetal proteins is essential to the study of two important aspects of fetal amino acid metabolism, namely a comparison of fetal amino acid utilization in net protein synthesis with other synthetic and catabolic pathways and the measurement of protein turnover rate. In the case of an essential amino acidsuch as lysine, the net rate of accumulation due to growth (LYs,,~) plus the rate of metabolism by routes other than protein synthesis (Lyhet) must be equal to the exogenous entry rate via the placenta (LysexO) Lemons et al. (7) estimated the exogenous lysine entry rate into the fetus to be 2.2 mmole kg-' *day-' in a group of sheep with average fetal age 130 days. In the present study, four fetuses with average age 125 days had a mean exogenous lysine entry rate of 3.4 mm01 l kg-'. day-'. Differences in fetal age and nutrition are likely to influence the Lysexo value, but there is no adequate information on this point. The fetal lysine requirements due to growth (LY sgroW) can be estimated from a fetal growth curve (6) and measurements of total lysine in the fetal body ( Table  2) . The estimated Lys,,, at 125 days is 1.8 mmol. kg-' l day -l, i.e., less than the measured rate of entry of exogenous lysine. This implies fetal metabolism of lysine in addition to that used for protein synthesis. The present finding that a fetal lamb infused with L-[U-'4C]lysine excretes 14C02 via the placenta demonstrates an active catabolic pathway of lysine in the ovine fetus.
Net utilization rates of an essential amino acid by growth and catabolism are the most important considerations in establishing the fetal nutritional needs for that amino acid. However, from the point of view of the energy cost of fetal development, it is important to recognize that growth as reflected in net protein accretion is the resultant of two opposite rates, i.e., synthesis and degradation of tissue proteins. In the presence of a fast rate of protein degradation even a zero growth rate would require that a large amount of energy be spent in protein synthesis. Hence, there is considerable physiological significance to comparisons of fetal growth rates with fetal rates of protein synthesis.
The results of our investigation demonstrate that the infusion of L-[U-'4C]lysine into a fetal vein produces a steady concentration of free radioactive lysine in fetal arterial plasma, during the 2-to 13-h period of the infusion. The simplest use of this information would be to calculate a plasma lysine turnover rate (R) from the infusion rate of the labeled lysine (I) and the specific activity of free plasma lysine at steady state (FL&, according to the equation
R=I+F&x (4)
This approach, which has been used extensively in wholebody amino acid turnover studies (5, 14) , would have the advantage that no analysis of radioactivity in the fetal carcass is required. However, the application of Eq. 4 to the fetal infusion of a labeled substance cannot provide a reliable estimate of its utilization by the fetus because a potentially large and variable fraction of the infused tracer may escape into the placenta and the mother. In the case of lysine this fraction is approximately 27% (see Fig. 2 ). Therefore we adopted a more elaborate procedure in which the specific activity of lysine was measured in both fetal plasma and carcass. This procedure allowed us to calculate the rate of incorporation of plasma lysine into fetal proteins. Given the fact that body proteins have widely different turnover rates and that there is intracellular recycling of amino acids, the calculated rate is a minimum estimate of the actual rate of incorporation of lysine into proteins. Despite this limitation, the results warrant two interesting conclusions. The first is that a large fraction of protein synthesis in the fetal lamb is devoted to protein turnover, i.e., resynthesis of tissue proteins that undergo continuous degradation. This conclusion is based on a comparison of the measured fractional rate of protein synthesis, KS, with the fractional rate of protein accretion by growth, Ko (Fig. 4) . The growth curve of fetal lambs has been studied by several investigators. There is general agreement that the percent increment of fetal weight is approximately 4%/day at 110 days gestation and then declines toward term. The Fetal sheep data are from Table 1 .
& line shown in Fig. 5 was derived from a recent study of the fetal body weight growth curve (6) and knowledge of fetal body protein content at different ages (Table 1 ).
It is apparent that the rate of protein synthesis is 2-4 times greater than the rate of protein accretion. The second conclusion is that the fractional rate of protein synthesis declines as the fetus grows (Fig. 4) . A rapid decline in relation to body size has also been observed in extrauterine life, as demonstrated by comparing the data obtained in fetal sheep with data for postnatal growth in rat (9) and man (16) (Fig. 5) . Protein turnover varies in inverse relation to body weight, both within and among species. Differences in whole-body turnover rate between small and large adult mammals are related in part to differences in the relative size of the major organs (5,lO) and in part to the fact that some organs of the small animal synthesize and degrade proteins more rapidly (5) . The physiological meaning of the latter finding is ob-
